Quantbot Technologies LP Reduces Stake in Trinity Capital Inc. $TRIN

Quantbot Technologies LP lessened its holdings in shares of Trinity Capital Inc. (NASDAQ:TRIN) by 92.9% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 11,078 shares of the company’s stock after selling 144,773 shares during the period. Quantbot Technologies LP’s holdings in Trinity Capital were worth $171,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in TRIN. First Horizon Advisors Inc. acquired a new position in Trinity Capital in the second quarter valued at approximately $32,000. MCF Advisors LLC acquired a new stake in Trinity Capital during the third quarter worth approximately $52,000. Allworth Financial LP purchased a new stake in shares of Trinity Capital during the 2nd quarter worth approximately $53,000. JPMorgan Chase & Co. purchased a new stake in shares of Trinity Capital during the 2nd quarter worth approximately $54,000. Finally, Blue Trust Inc. boosted its holdings in shares of Trinity Capital by 63.2% in the 3rd quarter. Blue Trust Inc. now owns 9,679 shares of the company’s stock valued at $150,000 after buying an additional 3,750 shares in the last quarter. Hedge funds and other institutional investors own 24.62% of the company’s stock.

Insider Activity

In related news, CEO Kyle Steven Brown purchased 3,333 shares of the stock in a transaction that occurred on Monday, March 2nd. The shares were purchased at an average price of $14.90 per share, with a total value of $49,661.70. Following the completion of the acquisition, the chief executive officer directly owned 376,775 shares in the company, valued at $5,613,947.50. This represents a 0.89% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders bought a total of 7,741 shares of company stock worth $115,358 over the last 90 days. Company insiders own 5.31% of the company’s stock.

Trending Headlines about Trinity Capital

Here are the key news stories impacting Trinity Capital this week:

• Positive Sentiment: Multiple insider purchases from Chairman Steve Louis Brown and Director Ronald E. Estes — small open-market buys on March 9–11 that increased their holdings (Brown bought 2,103 shares total across filings; Estes bought 605 shares total). Insider accumulation is a commonly bullish signal for investors. SEC filing (Brown) SEC filing (Estes)
• Positive Sentiment: Trinity committed $35 million in growth capital to Neuros Medical to support commercialization of a neuromodulation therapy (Altius system). This adds yield-generating assets to TRIN’s portfolio and supports future fee and interest income. Press release
• Positive Sentiment: Trinity provided $20 million in growth capital to Emboline to commercialize the Emboliner® embolic protection system for TAVR procedures — another MedTech deployment that broadens TRIN’s portfolio exposures and potential interest/fee income. Press release
• Neutral Sentiment: Coverage pick-up on the Neuros Medical deal from MonitorDaily restates the $35M commitment; useful for visibility but unlikely to move fundamentals beyond the original PR. Article
• Negative Sentiment: Seeking Alpha flagged a rating downgrade on TRINZ (7.875% Notes due 2029) and notes the notes are likely to be called after March 2026 as Trinity pursues cheaper secured refinancing. While the firm shows stable credit quality and contained NPLs, refinancing and a rating cut create near-term funding and perception risks that can pressure the stock and cost of capital. Article

Trinity Capital Price Performance

TRIN stock opened at $14.80 on Thursday. The company has a fifty day moving average price of $15.71 and a 200 day moving average price of $15.41. Trinity Capital Inc. has a 12 month low of $12.50 and a 12 month high of $17.20. The company has a market cap of $1.23 billion, a price-to-earnings ratio of 7.55 and a beta of 0.55.

Trinity Capital (NASDAQ:TRIN) last issued its quarterly earnings data on Wednesday, February 25th. The company reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.51 by $0.01. The company had revenue of $58.89 million for the quarter, compared to the consensus estimate of $79.83 million. Trinity Capital had a net margin of 46.18% and a return on equity of 14.97%. As a group, analysts anticipate that Trinity Capital Inc. will post 2.06 earnings per share for the current year.

Trinity Capital Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Friday, March 13th will be paid a dividend of $0.17 per share. The ex-dividend date is Friday, March 13th. This represents a c) annualized dividend and a dividend yield of 13.8%. Trinity Capital’s dividend payout ratio is 104.08%.

Analyst Ratings Changes

A number of research firms recently commented on TRIN. Citigroup reaffirmed an “outperform” rating on shares of Trinity Capital in a research report on Tuesday, January 27th. Noble Financial began coverage on shares of Trinity Capital in a research report on Thursday, December 11th. They issued a “buy” rating for the company. Capital One Financial set a $17.00 price objective on shares of Trinity Capital in a research note on Thursday, December 11th. Loop Capital set a $17.00 price objective on Trinity Capital in a report on Thursday, December 11th. Finally, Clear Str upgraded Trinity Capital to a “strong-buy” rating in a research report on Wednesday, February 4th. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $16.29.

Trinity Capital Company Profile

Trinity Capital Corporation (NASDAQ: TRIN) is a publicly traded business development company that provides flexible financing solutions to venture-backed and growth-stage companies. As a venture lender, Trinity Capital offers customized capital structures, including secured debt and equity co-investment, designed to support companies that have progressed beyond early-stage funding but still require non-dilutive growth capital.

The company focuses its investments on technology-driven sectors such as software, fintech, healthcare, life sciences and cleantech.